EXERCISE TRAINING WITH OR WITHOUT MEDICATIONCONTROL
EXERCISE TRAINING WITH OR WITHOUT MEDICATION: Posture exercise, stretching exercise, breathing exercise, back strengthening exercise, self-mobilization exercise, cat camel exercise and postural correction exercise will be applied.
CONTROL: Posture exercise, stretching exercise, breathing exercise, back strengthening exercise, self-mobilization exercise, cat camel exercise will be applied.
Study summary
Kyphosis-oriented exercise programs consist of isolated stretching, strengthening, and breathing exercises. However, the literature emphasizes that the body is a kinetic chain in many musculoskeletal disorders and supports holistic exercise approaches. To our knowledge, the effects of a complex exercise such as the Wall Angels exercise have not been studied in the kyphotic population. The aim of our study is to investigate whether the Wall Angels exercise combined with standard kyphosis exercises performed at home has additional effects and to contribute to the optimization of kyphosis rehabilitation programs.
Eligibility
Sex
ALL
Min age
18 Years
Max age
30 Years
Healthy volunteers
No
Inclusion Criteria:
1. Volunteering to participate in the study and giving written consent
2. Being a woman/man between the ages of 18-25
3. Having a kyphotic posture
Exclusion Criteria:
1. Having a musculoskeletal disorder (scoliosis, etc.)
2. Having a neurological system disorder
3. Having a cardiopulmonary system disorder
4. Having a fracture or surgery related to the spine, rib cage, or upper extremity within the last year
5. Participating in an exercise program for kyphosis within the last 6 months
Primary outcome measure(s)
Postural Habits and Awareness Scale — From enrollment to the end of treatment at 6 weeks Postural habits and awareness levels will be assessed with the Postural Habits and Awareness Scale (PHAS). PHAS is a valid and reliable tool developed to assess postural habits and awareness in healthy adults. This scale consists of four sub-dimensions: postural habits and awareness, awareness of factors that impair posture, ergonomic awareness and positional awareness. PHAS is structured as a 5-point Likert scale consisting of 19 items, 7 of which are related to postural habits and 12 to postural awareness. Participants rate each item on a scale ranging from 1 (strongly disagree) to 5 (strongly agree). The total score on the scale ranges from 0 to 95, with higher scores indicating better postural habits and awareness.
Visual Analog Scale (VAS) — From enrollment to the end of treatment at 6 weeks The level of pain will be assessed by the participant using the Visual Analog Scale (VAS) (0: no pain; 100: unbearable pain).
Trunk Hyperextension and Lateral Flexion Flexibility Measurement — From enrollment to the end of treatment at 6 weeks Trunk flexibility will be measured using trunk hyperextension and lateral flexion (for right and left sides) tests and a tape measure. For the trunk hyperextension measurement, the participant is asked to stand facing the wall and with their pelvis touching the wall. First, the distance between the sternum notch and the wall is measured and recorded in this position. Then, the participant's pelvis is supported and they are asked to move their trunk backwards away from the wall. At the last point, the sternum notch and wall distance is measured again. The difference between the first and last measurements is recorded in centimeters. For the trunk lateral flexion measurement, the participant stands with their back to the wall. The tape measure is placed distal to the 3rd phalanx. The measure is recorded in centimeters. The measurement is repeated for the other side.
Flexruler Measurement (kyphosis index) — From enrollment to the end of treatment at 6 weeks The kyphosis index will be calculated using the appropriate formula after the measurement with the flexible ruler. The flexible ruler is a metal covered with plastic, approximately 60 cm long, which can be molded according to the contour of the spine to measure the curves in the sagittal plane. To determine the kyphosis index, the spinous processes of the C7 and T12 vertebrae are determined as references and the participant's kyphosis shape is evaluated with the flexible ruler and transferred to paper. The kyphosis index is calculated by evaluating the angle formed between the distance between C7 and T12, defined as thoracic length, and the distance of the kyphosis peak, defined as thoracic width, to the thoracic length line.
Inclinometer Tests — From enrollment to the end of treatment at 6 weeks Thoracic range of motion will be measured using an inclinometer for flexion and rotation (for the right and left sides). The spinous processes of the T1 and T12 vertebrae are marked as reference points. For the measurement of thoracic flexion, the inclinometer is placed vertically on the T1 vertebra and the participant is asked to lean forward so that the lumbar region does not participate in the movement. The value obtained at this point is recorded in degrees for the T1 vertebra flexion. Immediately afterwards, the inclinometer is placed vertically on the T12 vertebra and the T12 vertebra flexion is recorded in degrees. For thoracic right and left rotations, the inclinometer is placed horizontally on the T1 vertebra. The participant is asked to rotate the thoracic region and the value at the last point is recorded in degrees for the T1 vertebra. Immediately afterwards, the degree for the T12 vertebra is recorded.
Scapula Protraction Test — From enrollment to the end of treatment at 6 weeks For the right and left scapula, the inferior edge of the scapula is determined and the vertical distance to the midline of the spine is measured with a tape measure and recorded in centimeters.
Chest Circumference Measurement — From enrollment to the end of treatment at 6 weeks Respiratory capacity will be recorded in centimeters by taking the difference between the chest circumference measurements obtained at maximum inspiration and maximum expiration from the axillary, epigastric and subcostal regions. The greater the difference, the better the pulmonary function.
the Quick Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire — From enrollment to the end of treatment at 6 weeks The DASH is a questionnaire designed to assess disability resulting from upper extremity injuries, activity limitations, leisure activities, and work participation restrictions. The questionnaire consists of three sections. The first section contains 30 items: 21 items assessing difficulties in activities of daily living, 5 items assessing symptoms, and 4 items assessing social function, work, sleep, and self-esteem. This first section determines the Function/Symptom Model (DASH-FS) score. All questions are scored on a 5-point Likert-type scale (1: no difficulty, 5: cannot do at all) (0: no disability, 100: maximum disability). Scores range from 0 to 100 for each section (0: no disability, 100: maximum disability).
SRS22 Patient Outcome Questionnaires — From enrollment to the end of treatment at 6 weeks Quality of life will be assessed with the Scoliosis Research Society Patient Questionnaire. The SRS-22 is a valid and reliable scoliosis-specific quality of life scale developed by Haher et al. and modified by the Scoliosis Research Society to assess the current perception of medical status and self-image in patients with idiopathic scoliosis. The scale consists of five subscales consisting of 22 questions, including pain, general body image, spine function, mental health, and treatment satisfaction. Participants rate each question on a scale of 1 (most negative) to 5 (most positive). Scores for each subscale range from 0 to 25, while the total score for treatment satisfaction ranges from 0 to 10. Higher scores on the scale indicate improved quality of life, while lower scores reflect decreased quality of life.
Trial sites (1)
Facility
City
Region
Status
Suleyman Demirel University Faculty of Health Science
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.